Kyntra Bio (KYNB)CEO bought ~$20K

~$20K

Approx. value · 2,800 sh @ $7.09

27K

Holds after · shares reported

Traded

May 14, 2026

Filed

May 19, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 16, 2026Company filing · Form 8-K · ResultsReported its results
2. Apr 2, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On April 2, 2026, Kyntra Bio, Inc. (“Kyntra Bio” or the “Company”) received a letter from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market notifying us that the Company no longer complies with the Nasdaq Global Select Market continued listing requirement of $50 million in total assets and total revenue for the most recently completed fiscal year (or two of the last three most recently completed…”
3. May 11, 2026Company filing · Form 8-K · ResultsReported its results
4. May 14, 2026 · this disclosureInsiderCEO purchased ~$20K of KYNB shares in the open market

What came next

1. Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
2. Aug 31, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Kyntra Bio

OQRO holds no insider, Congress, fund or contract record for Kyntra Bio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KYNB page.

Other recent filings by Thane Wettig, CEO

• SEC Form 4 at Kyntra Bio (KYNB)Nov 18, 2025
• SEC Form 4 at Kyntra Bio (KYNB)Nov 18, 2025
• SEC Form 4 at Kyntra Bio (KYNB)Mar 25, 2025

The full history of Thane Wettig, CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Kyntra Bio

• SEC Form 4Nov 18, 2025
• SEC Form 4Nov 18, 2025
• SEC Form 4Jul 2, 2025
• SEC Form 4Mar 25, 2025
• SEC Form 4Mar 24, 2025
• SEC Form 4Mar 24, 2025

Everything OQRO holds on this company is on its KYNB page.